FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4234674179> ?p ?o ?g. }

• W4234674179 abstract "Abstract Background Cameroon remains a country faced with high malaria burden despite enormous efforts made in the control of the disease. The rapid development and dispersal of mutations associated with anti - malarial drug resistance influenced policy changes from the use of chloroquine, amodiaquine and sulphadoxine - pyrimethamine to the adoption of artemisinin - based combination therapies (ACTs) for the treatment of uncomplicated falciparum malaria. Different studies have identified the frequency of key markers in Plasmodium falciparum associated with drug resistance without a clear picture on the localisation of potential hotspots that may drive the emergence of resistance to the currently used ACTs. This systematic review and meta - analysis aims to determine the prevalence and distribution of P. falciparum drug resistance markers within an evolving efficacy of anti - malarial drugs in Cameroon from 1990 to present.Methods The PRISMA, PRISMA - P and STREGA statements will be adopted in the quality assessments of studies to be included in this review. The electronic databases of Medline via Pubmed, Google Scholar and Science Direct will be searched by two independent researchers using different MeSH terms and Boolean operators (AND, OR). More so, unpublished data that will be sourced from academic libraries will also be extracted. Quantitative syntheses will be done using the “metaphor” and “meta” commands in the R statistical software package version 3.5.2. Heterogeneity will be assessed using Cochrane Q and the I 2 . The random effect model will be used as benchmark to combine studies showing heterogeneity.Discussion The primary outcome of this review is to identify and describe molecular markers conferring drug resistance in Plasmodium falciparum parasites that have been circulating for a period of over 30 years in Cameroon. This review will be able to pool data from previously published and unpublished studies on anti - malarial drug resistance gene mutations. This will provide evidence to support the continuous use of ACTs in the treatment of uncomplicated P. falciparum malaria. Moreover, it is also hoped that potential hotspots driving the emergence and spread of anti - malarial resistance markers will be identified.Systematic review registration: PROSPERO submission identification number is 162620" @default.
• W4234674179 created "2022-05-12" @default.
• W4234674179 creator A5000400954 @default.
• W4234674179 creator A5016318683 @default.
• W4234674179 creator A5023957519 @default.
• W4234674179 creator A5026372935 @default.
• W4234674179 creator A5026960858 @default.
• W4234674179 creator A5030491812 @default.
• W4234674179 creator A5034042474 @default.
• W4234674179 creator A5036327735 @default.
• W4234674179 creator A5037036664 @default.
• W4234674179 creator A5038112448 @default.
• W4234674179 creator A5039298451 @default.
• W4234674179 creator A5039722694 @default.
• W4234674179 creator A5043406174 @default.
• W4234674179 creator A5049427727 @default.
• W4234674179 creator A5056093448 @default.
• W4234674179 creator A5059057536 @default.
• W4234674179 creator A5063078833 @default.
• W4234674179 creator A5067442660 @default.
• W4234674179 creator A5067561961 @default.
• W4234674179 creator A5068090166 @default.
• W4234674179 creator A5068770175 @default.
• W4234674179 creator A5072828100 @default.
• W4234674179 creator A5076223187 @default.
• W4234674179 creator A5080218025 @default.
• W4234674179 creator A5082924641 @default.
• W4234674179 creator A5085522877 @default.
• W4234674179 date "2020-05-14" @default.
• W4234674179 modified "2023-09-26" @default.
• W4234674179 title "Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis protocol" @default.
• W4234674179 doi "https://doi.org/10.21203/rs.3.rs-26096/v1" @default.
• W4234674179 hasPublicationYear "2020" @default.
• W4234674179 type Work @default.
• W4234674179 citedByCount "0" @default.
• W4234674179 crossrefType "posted-content" @default.
• W4234674179 hasAuthorship W4234674179A5000400954 @default.
• W4234674179 hasAuthorship W4234674179A5016318683 @default.
• W4234674179 hasAuthorship W4234674179A5023957519 @default.
• W4234674179 hasAuthorship W4234674179A5026372935 @default.
• W4234674179 hasAuthorship W4234674179A5026960858 @default.
• W4234674179 hasAuthorship W4234674179A5030491812 @default.
• W4234674179 hasAuthorship W4234674179A5034042474 @default.
• W4234674179 hasAuthorship W4234674179A5036327735 @default.
• W4234674179 hasAuthorship W4234674179A5037036664 @default.
• W4234674179 hasAuthorship W4234674179A5038112448 @default.
• W4234674179 hasAuthorship W4234674179A5039298451 @default.
• W4234674179 hasAuthorship W4234674179A5039722694 @default.
• W4234674179 hasAuthorship W4234674179A5043406174 @default.
• W4234674179 hasAuthorship W4234674179A5049427727 @default.
• W4234674179 hasAuthorship W4234674179A5056093448 @default.
• W4234674179 hasAuthorship W4234674179A5059057536 @default.
• W4234674179 hasAuthorship W4234674179A5063078833 @default.
• W4234674179 hasAuthorship W4234674179A5067442660 @default.
• W4234674179 hasAuthorship W4234674179A5067561961 @default.
• W4234674179 hasAuthorship W4234674179A5068090166 @default.
• W4234674179 hasAuthorship W4234674179A5068770175 @default.
• W4234674179 hasAuthorship W4234674179A5072828100 @default.
• W4234674179 hasAuthorship W4234674179A5076223187 @default.
• W4234674179 hasAuthorship W4234674179A5080218025 @default.
• W4234674179 hasAuthorship W4234674179A5082924641 @default.
• W4234674179 hasAuthorship W4234674179A5085522877 @default.
• W4234674179 hasBestOaLocation W42346741791 @default.
• W4234674179 hasConcept C114851261 @default.
• W4234674179 hasConcept C126322002 @default.
• W4234674179 hasConcept C189708586 @default.
• W4234674179 hasConcept C203014093 @default.
• W4234674179 hasConcept C2776478404 @default.
• W4234674179 hasConcept C2776992834 @default.
• W4234674179 hasConcept C2777199930 @default.
• W4234674179 hasConcept C2777425658 @default.
• W4234674179 hasConcept C2778048844 @default.
• W4234674179 hasConcept C2778371730 @default.
• W4234674179 hasConcept C2779473830 @default.
• W4234674179 hasConcept C54355233 @default.
• W4234674179 hasConcept C55493867 @default.
• W4234674179 hasConcept C71924100 @default.
• W4234674179 hasConcept C86803240 @default.
• W4234674179 hasConcept C95190672 @default.
• W4234674179 hasConcept C98274493 @default.
• W4234674179 hasConceptScore W4234674179C114851261 @default.
• W4234674179 hasConceptScore W4234674179C126322002 @default.
• W4234674179 hasConceptScore W4234674179C189708586 @default.
• W4234674179 hasConceptScore W4234674179C203014093 @default.
• W4234674179 hasConceptScore W4234674179C2776478404 @default.
• W4234674179 hasConceptScore W4234674179C2776992834 @default.
• W4234674179 hasConceptScore W4234674179C2777199930 @default.
• W4234674179 hasConceptScore W4234674179C2777425658 @default.
• W4234674179 hasConceptScore W4234674179C2778048844 @default.
• W4234674179 hasConceptScore W4234674179C2778371730 @default.
• W4234674179 hasConceptScore W4234674179C2779473830 @default.
• W4234674179 hasConceptScore W4234674179C54355233 @default.
• W4234674179 hasConceptScore W4234674179C55493867 @default.
• W4234674179 hasConceptScore W4234674179C71924100 @default.
• W4234674179 hasConceptScore W4234674179C86803240 @default.
• W4234674179 hasConceptScore W4234674179C95190672 @default.
• W4234674179 hasConceptScore W4234674179C98274493 @default.
• W4234674179 hasLocation W42346741791 @default.
• W4234674179 hasLocation W42346741792 @default.
• W4234674179 hasOpenAccess W4234674179 @default.

• next